CorMedix (CRMD) PT Raised to $18 at Truist Securities

October 18, 2022 9:43 AM EDT
Get Alerts CRMD Hot Sheet
Price: $8.14 +14.65%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Truist Securities analyst Joon Lee raised the price target on CorMedix (NASDAQ: CRMD) to $18.00 (from $16.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change